US5560922A
(en)
*
|
1986-05-30 |
1996-10-01 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
|
US5229129A
(en)
*
|
1989-07-12 |
1993-07-20 |
Cygnus Therapeutic Systems |
Transdermal administration of lisuride
|
NZ237241A
(en)
*
|
1990-03-02 |
1993-11-25 |
Pharmetrix Corp |
Method for increasing the storage stability of physostigmine
|
EP0523150A4
(en)
*
|
1990-04-06 |
1993-09-29 |
Pharmetrix Corporation |
Device and method for enhanced administration of physostigmine
|
US5225198A
(en)
*
|
1991-08-27 |
1993-07-06 |
Cygnus Therapeutic Systems |
Transdermal administration of short or intermediate half-life benzodiazepines
|
US5705185A
(en)
*
|
1991-09-25 |
1998-01-06 |
Beta Pharmaceuticals Co. |
Transdermal delivery of estradiol and process for manufacturing said device
|
US5518734A
(en)
*
|
1991-09-25 |
1996-05-21 |
Beta Pharmaceuticals Co. |
Transdermal delivery system for estradiol and process for manufacturing said device
|
US5229130A
(en)
*
|
1991-12-20 |
1993-07-20 |
Cygnus Therapeutics Systems |
Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
|
US5453279A
(en)
*
|
1992-04-21 |
1995-09-26 |
Tbs Laboratories, Inc. |
Enhancing transdermal absorption compositions; transdermal dosage form; and process
|
US6676967B1
(en)
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
JPH0827003A
(ja)
*
|
1994-07-22 |
1996-01-30 |
Sekisui Chem Co Ltd |
経皮吸収製剤
|
CA2198390C
(en)
|
1994-09-14 |
2009-08-11 |
James E. Garbe |
Matrix for transdermal drug delivery
|
GB9500116D0
(en)
*
|
1995-01-05 |
1995-03-01 |
Ciba Geigy Ag |
Pharmaceutical compositions
|
US5573778A
(en)
*
|
1995-03-17 |
1996-11-12 |
Adhesives Research, Inc. |
Drug flux enhancer-tolerant pressure sensitive adhesive composition
|
US5882676A
(en)
*
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
DK1563788T3
(da)
|
1995-08-29 |
2015-05-11 |
Nitto Denko Corp |
Mikroperforering af human hud til stofindgift og overvågningsformål
|
DE19548332A1
(de)
*
|
1995-12-22 |
1997-07-10 |
Rotta Res Bv |
Hormonpflaster
|
AU2036297A
(en)
*
|
1996-03-20 |
1997-10-10 |
Glaxo Group Limited |
Topical formulations of aciclovir
|
IT1283102B1
(it)
*
|
1996-06-06 |
1998-04-07 |
Permatec Nv |
Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
|
DK0934078T3
(da)
*
|
1996-10-24 |
2003-04-14 |
Alza Corp |
Permeabilitetsfremmere til transdermal administrering af aktivstoffer, anordninger og fremgangsmåde til fremstilling deraf
|
JP2001503749A
(ja)
*
|
1996-10-30 |
2001-03-21 |
セラテック・インコーポレーテッド |
透過促進剤としてのグリコール酸の脂肪酸エステル及びその塩
|
KR100215027B1
(ko)
*
|
1997-01-27 |
1999-08-16 |
성재갑 |
스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형
|
KR100294084B1
(ko)
*
|
1998-06-02 |
2001-09-22 |
성재갑 |
비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형
|
US6572874B1
(en)
*
|
1998-05-15 |
2003-06-03 |
Umd, Inc. |
Vaginal delivery of bisphosphonates
|
IT1294748B1
(it)
|
1997-09-17 |
1999-04-12 |
Permatec Tech Ag |
Formulazione per un dispositivo transdermico
|
US6046244A
(en)
*
|
1997-11-05 |
2000-04-04 |
Nexmed Holdings, Inc. |
Topical compositions for prostaglandin E1 delivery
|
US6414028B1
(en)
*
|
1997-11-05 |
2002-07-02 |
Nexmed Holdings, Inc. |
Topical compositions containing prostaglandin E1
|
WO1999032153A1
(en)
|
1997-12-22 |
1999-07-01 |
Alza Corporation |
Monoglyceride and ethyl palmitate permeation enhancer compositions
|
DE19814084B4
(de)
*
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
RU2203058C2
(ru)
*
|
1998-04-27 |
2003-04-27 |
Фудзисава Фармасьютикал Ко., Лтд. |
Фармацевтическая композиция
|
FR2761600B1
(fr)
|
1998-06-19 |
2000-03-31 |
Oreal |
Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
|
GB9825402D0
(en)
†
|
1998-11-19 |
1999-01-13 |
Pfizer Ltd |
Antiparasitic formulations
|
US20030078499A1
(en)
*
|
1999-08-12 |
2003-04-24 |
Eppstein Jonathan A. |
Microporation of tissue for delivery of bioactive agents
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
EP1325752A3
(en)
*
|
2000-08-03 |
2003-08-06 |
Antares Pharma IPL AG |
Composition for transdermal and/or transmucosal administration of active compounds which ensures adequate therapeutic levels
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
DE10041478A1
(de)
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
US6803420B2
(en)
|
2001-05-01 |
2004-10-12 |
Corium International |
Two-phase, water-absorbent bioadhesive composition
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
RU2276998C2
(ru)
|
2001-05-01 |
2006-05-27 |
Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук |
Гидрогелевые композиции
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
IL161786A0
(en)
*
|
2001-11-29 |
2005-11-20 |
3M Innovative Properties Co |
Pharmaceutical formulations comprising an immune
|
DE10159120B4
(de)
*
|
2001-12-01 |
2006-08-17 |
Lts Lohmann Therapie-Systeme Ag |
Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
US8116860B2
(en)
|
2002-03-11 |
2012-02-14 |
Altea Therapeutics Corporation |
Transdermal porator and patch system and method for using same
|
US9918665B2
(en)
|
2002-03-11 |
2018-03-20 |
Nitto Denko Corporation |
Transdermal porator and patch system and method for using same
|
ES2612779T3
(es)
*
|
2002-03-11 |
2017-05-18 |
Nitto Denko Corporation |
Sistema de parches transdérmicos de administración de fármacos, método de fabricación del mismo y método de uso del mismo
|
US20030199584A1
(en)
*
|
2002-04-11 |
2003-10-23 |
Ahluwalia Gurpreet S. |
Reduction of hair growth
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
DE10234673B4
(de)
*
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
ATE423560T1
(de)
*
|
2002-08-20 |
2009-03-15 |
Euro Celtique Sa |
Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
|
JP2006516047A
(ja)
|
2002-10-28 |
2006-06-15 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
マグネットクランプを備えた経皮アッセイ
|
ATE295726T1
(de)
*
|
2002-12-02 |
2005-06-15 |
Sanol Arznei Schwarz Gmbh |
Verabreichung von rotigotine zur behandlung der parkinson'schen krankheit durch iontophorese
|
CA2729967C
(en)
*
|
2002-12-13 |
2018-01-16 |
Schering-Plough Healthcare Products, Inc. |
Use of a transdermal or transmucosal ingredient delivery device
|
JP4542743B2
(ja)
*
|
2002-12-26 |
2010-09-15 |
Kdl株式会社 |
ピリドン誘導体の溶液状医薬組成物
|
DE10261696A1
(de)
*
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
US7858607B2
(en)
*
|
2003-03-14 |
2010-12-28 |
Mamchur Stephen A |
System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
|
US20040241223A1
(en)
*
|
2003-05-27 |
2004-12-02 |
David Wong |
Oral dosage forms for macromolecular drugs
|
US7576226B2
(en)
*
|
2003-06-30 |
2009-08-18 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Process of making isomers of norelgestromin and methods using the same
|
EP1648363B1
(en)
|
2003-07-03 |
2019-03-06 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
PL1670433T3
(pl)
*
|
2003-10-10 |
2013-03-29 |
Ferring Bv |
Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
|
US8016811B2
(en)
|
2003-10-24 |
2011-09-13 |
Altea Therapeutics Corporation |
Method for transdermal delivery of permeant substances
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US8658201B2
(en)
|
2004-01-30 |
2014-02-25 |
Corium International, Inc. |
Rapidly dissolving film for delivery of an active agent
|
WO2005077364A1
(ja)
*
|
2004-02-18 |
2005-08-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
ソリフェナシンの経皮投与製剤およびその経皮透過改善方法
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
AU2005275173A1
(en)
*
|
2004-07-15 |
2006-02-23 |
Freedom-2, Inc. |
Modified tissue marking pigment and method for modifying tissue marking pigment
|
RU2393877C2
(ru)
|
2004-08-05 |
2010-07-10 |
Кориум Интернэшнл, Инк. |
Адгезивная композиция
|
WO2006091697A1
(en)
|
2005-02-23 |
2006-08-31 |
Psychenomics, Inc. |
Dopamine transporter inhibitors for use in treatment of movement disorders and other cns indications
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
US20070065494A1
(en)
*
|
2005-08-03 |
2007-03-22 |
Watson Laboratories, Inc. |
Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
|
US10137135B2
(en)
*
|
2005-08-15 |
2018-11-27 |
Allergan Sales, Llc |
Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
|
NZ571460A
(en)
|
2006-04-21 |
2010-10-29 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
DE102006050558B4
(de)
|
2006-10-26 |
2009-03-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
|
WO2009018356A1
(en)
*
|
2007-07-30 |
2009-02-05 |
Medacure International, Inc. |
Immune system modulator formulation
|
US20090098191A1
(en)
*
|
2007-10-16 |
2009-04-16 |
Anderson Christopher G |
Use of bases to stabilize transdermal formulations
|
US8609733B2
(en)
*
|
2008-05-19 |
2013-12-17 |
Massachusetts Institute Of Technology |
Sensory-specific local anesthesia and prolonged duration local anesthesia
|
WO2009143174A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Children's Medical Center Corporation |
Chemical permeation enhancers enhance nerve blockade by toxins
|
US8784879B2
(en)
|
2009-01-14 |
2014-07-22 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
WO2012018486A2
(en)
|
2010-07-26 |
2012-02-09 |
Seventh Sense Biosystems, Inc. |
Rapid delivery and/or receiving of fluids
|
US9295417B2
(en)
|
2011-04-29 |
2016-03-29 |
Seventh Sense Biosystems, Inc. |
Systems and methods for collecting fluid from a subject
|
CN102405015B
(zh)
|
2009-03-02 |
2017-01-18 |
第七感生物系统有限公司 |
用于分析可提取介质的装置和方法
|
WO2010101625A2
(en)
|
2009-03-02 |
2010-09-10 |
Seventh Sense Biosystems, Inc. |
Oxygen sensor
|
US9033898B2
(en)
|
2010-06-23 |
2015-05-19 |
Seventh Sense Biosystems, Inc. |
Sampling devices and methods involving relatively little pain
|
US8957207B2
(en)
|
2009-03-24 |
2015-02-17 |
Proteus S.A. |
Methods for producing phycotoxins
|
WO2011000210A1
(zh)
*
|
2009-07-01 |
2011-01-06 |
润和生物医药科技(汕头)有限公司 |
促渗剂组合物及其透皮给药系统中的应用
|
WO2011017520A1
(en)
|
2009-08-05 |
2011-02-10 |
Wake Forest University Health Sciences |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
WO2011094573A1
(en)
|
2010-01-28 |
2011-08-04 |
Seventh Sense Biosystems, Inc. |
Monitoring or feedback systems and methods
|
JP6022442B2
(ja)
|
2010-05-14 |
2016-11-09 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
男性用避妊組成物および使用方法
|
CN103068308B
(zh)
|
2010-07-16 |
2016-03-16 |
第七感生物系统有限公司 |
用于流体传输装置的低压环境
|
US20120039809A1
(en)
|
2010-08-13 |
2012-02-16 |
Seventh Sense Biosystems, Inc. |
Systems and techniques for monitoring subjects
|
EP2992827B1
(en)
|
2010-11-09 |
2017-04-19 |
Seventh Sense Biosystems, Inc. |
Systems and interfaces for blood sampling
|
US20130158468A1
(en)
|
2011-12-19 |
2013-06-20 |
Seventh Sense Biosystems, Inc. |
Delivering and/or receiving material with respect to a subject surface
|
KR102237667B1
(ko)
|
2011-04-29 |
2021-04-12 |
세븐쓰 센스 바이오시스템즈, 인크. |
유체들의 전달 및/또는 수용
|
EP3236259A1
(en)
|
2011-04-29 |
2017-10-25 |
Seventh Sense Biosystems, Inc. |
Plasma or serum production and removal of fluids under reduced pressure
|
KR20140054248A
(ko)
*
|
2011-08-25 |
2014-05-08 |
니프로 패치 가부시키가이샤 |
함수 첩부제
|
DE102011119043A1
(de)
|
2011-11-22 |
2013-05-23 |
Alfred E. Tiefenbacher (Gmbh & Co. Kg) |
Transdermales therapeutisches System (TDS) mit Rotigotin
|
WO2013078422A2
(en)
|
2011-11-23 |
2013-05-30 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
MX367596B
(es)
*
|
2012-01-26 |
2019-08-27 |
Therapeuticsmd Inc |
Tratamientos transdermicos de sustitucion hormonal.
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
WO2014113541A1
(en)
|
2013-01-16 |
2014-07-24 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Attenuated chlamydia vaccine
|
EP2968225B1
(en)
|
2013-03-15 |
2019-02-20 |
The Children's Medical Center Corporation |
Neosaxitoxin combination formulations for prolonged local anesthesia
|
CA2908434C
(en)
|
2013-04-07 |
2021-12-28 |
The Broad Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
JP2016537360A
(ja)
|
2013-11-22 |
2016-12-01 |
ジェンザイム・コーポレーション |
神経変性疾患を治療するための新規な方法
|
US10801070B2
(en)
|
2013-11-25 |
2020-10-13 |
The Broad Institute, Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
NZ721908A
(en)
|
2013-12-20 |
2022-12-23 |
Massachusetts Gen Hospital |
Combination therapy with neoantigen vaccine
|
RU2016143081A
(ru)
|
2014-05-22 |
2018-06-26 |
Терапьютиксмд, Инк. |
Натуральные комбинированные гормонозаместительные составы и терапии
|
KR20170040209A
(ko)
|
2014-07-29 |
2017-04-12 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
경피 크림
|
EP3234193B1
(en)
|
2014-12-19 |
2020-07-15 |
Massachusetts Institute of Technology |
Molecular biomarkers for cancer immunotherapy
|
EP3234130B1
(en)
|
2014-12-19 |
2020-11-25 |
The Broad Institute, Inc. |
Methods for profiling the t-cell- receptor repertoire
|
WO2016187508A2
(en)
|
2015-05-20 |
2016-11-24 |
The Broad Institute Inc. |
Shared neoantigens
|
JP7257739B2
(ja)
*
|
2015-07-02 |
2023-04-14 |
ノーヴェン ファーマシューティカルズ インコーポレイテッド |
レボノルゲストレルおよびエチニルエストラジオールのための経皮的薬物送達システム
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
WO2017184590A1
(en)
|
2016-04-18 |
2017-10-26 |
The Broad Institute Inc. |
Improved hla epitope prediction
|
EP3574116A1
(en)
|
2017-01-24 |
2019-12-04 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
WO2020072700A1
(en)
|
2018-10-02 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|